Hypertension
Conditions
Keywords
Hypertension, workplace health, behavioral intervention, randomized controlled trial, Kailuan study
Brief summary
This study aims to evaluate the effectiveness of a workplace-based, multicomponent hypertension management program for newly diagnosed patients. Investigators will recruit 512 participants (256 pairs) from the Kailuan Study in Tangshan, China. Participants will be randomly assigned to receive a Workplace-based Multicomponent Hypertension Management Program or Standard Workplace Health Management. The primary objective is to assess improvements in blood pressure control and hypertension-related health behaviors.
Detailed description
Hypertension is a major public health issue worldwide, and workplace settings represent a critical intervention opportunity for middle-aged populations. Nudge theory provides a cost-effective and behaviorally informed approach to promote sustainable health behaviors. This randomized controlled trial (RCT) will explore mechanisms of health behavior promotion, evaluate the effectiveness of a nudge-based workplace health management strategy, and contribute to evidence-based hypertension prevention and control in China.
Interventions
Multicomponent strategies, including default scheduling of BP monitoring and counseling sessions, personalized reminders via workplace digital systems, social comparison feedback using anonymized peer data, small incentives and commitment devices.
Routine workplace health education and management according to current guidelines, including routine health education, standard hypertension counseling, and usual workplace health services.
Sponsors
Study design
Eligibility
Inclusion criteria
* Adults aged 18-60 years * Newly diagnosed hypertension (per 2024 Chinese hypertension guideline criteria) * Employed in Kailuan Group workplace settings * Able to provide informed consent
Exclusion criteria
* Severe cardiovascular or renal disease at baseline * Psychiatric disorders affecting compliance * Pregnant or lactating women * Participation in other intervention trials
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Change in systolic and diastolic blood pressure | up to 12 months | Change in systolic and diastolic blood pressure from baseline to 12 months |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Changes in hypertension-related health behaviors | up to 12 months | Changes in hypertension-related health behaviors (dietary intake, physical activity, medication adherence) at 12 months |
| Change in body mass index (BMI) | up to 12 months | Change in body mass index (BMI) at 12 months |
| Work productivity and quality of life scores | up to 12 months | Work productivity and quality of life scores (e.g., the European Quality of Life-5 Dimensions) at 12 months |
Countries
China